跳转到主要内容
搜索

CERTAINTY – 韩国

现场活动

GREATER CERTAINTY IN DRUG DEVELOPMENT

Certainty by Certara 为行业领导者和临床研究人员提供独享的机会,通过有关模型引导的药物开发、临床药理学、QSP、PBPK 等方面的演讲,使他们在药物开发中获得更好的确定性。

您可以从我们的特邀演讲嘉宾和 Certara 专家那里了解案例研究和最新科学趋势,并直接提问。我们希望这一年度盛会能帮助您与来自不同制药公司的创新研究人员建立联系,并将创新成果带到您的团队中。

Certara 特色主题演讲

  • FDA Project Optimus 和 MIDD 案例研究:从审批到超越
    by Mayumi Hasegawa PhD, Mayumi Hasegawa PhD, Sr. Consultant, Drug Development Solutions, Certara
  • PBPK 如何助力加速您的药物开发 — 案例研究
    by Noriko Okudaira, PhD, Sr Director of PBPK Consultancy, Simcyp
  • 制药业 AI 应用不再只是炒作:现实案例揭示技术革新力量
    Sean McGee, 产品总监
  • FDA expectations for drug development to support IND and NDA/BLA​
    by Geoff Fatzinger, VP, Regulatory Strategy, Certara
  • Biosimulation at scale:  Industrializing quantitative systems pharmacology to guide drug-development decision making​
    by  John M. Burke, PhD, VP, Global Head of ABM Scientific Affairs, Certara
  • 优化试验,直通提交:How Certara Cloud Optimizes Trials Towards Submission Readiness​
    Philip Johnston,Certara 产品副总裁
  • Gen AI 时代:重塑监管写作,引领革新浪潮
    by Heeyoung, Kim, Manager of Solution Consultant, APAC, Certara

特邀嘉宾

  • SPMED
  • GID Partners
  • MedClaris
  • Eyegene
Registration is now full

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software